Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Polysomnography Plus Outpatient Study to Determine the Safety and Efficacy of 4 mg Ramelteon in Adults With Chronic Insomnia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jan 2022
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Takeda; Takeda Global Research and Development Center
- 25 Jan 2022 This trial has been completed in Fingland, according to European Clinical Trials Database record. (28 Mar 2008)
- 21 Mar 2012 This trial is recruting in England, Finland and France.
- 21 Mar 2012 Planned patient number is 1200 according to European Clinical Trials Database.